Jon Cohen and Michael Hansen Join Talkspace’s Board of Directors
September 15 2022 - 4:05PM
Shareholders of Talkspace, Inc. (Nasdaq: TALK) today elected Jon
Cohen, M.D., to the virtual behavioral healthcare company’s board
of directors and approved all other shareholder proposals during
the company’s first Annual Meeting of Stockholders.
Dr. Cohen is prior Executive Chairman and Chief Executive
Officer of BioReference Laboratories and Senior Vice President of
OPKO Health (NASDAQ: OPK). Dr. Cohen brings 30 years of healthcare
industry strategy and operating experience to Talkspace’s board of
directors. He succeeds Jeffrey Crowe as an independent Class I
Director with a term expiring in 2025.
Additionally, the Company’s board appointed Cengage Group Chief
Executive Officer Michael Hansen to complete Charles Berg’s term as
a Class II director expiring in 2023. Mr. Hansen, a digital
transformation expert, previously served as partner and Chairman at
the Boston Consulting Group’s digital convergence practice. He’s
been named one of Fast Company’s Most Creative People in Business
and twice been recognized as a top CEO by Glassdoor.
Finally, Talkspace shareholders approved the
following proposals, all of which were supported by the Board:
- Re-election of Erez Shachar and
Madhu Pawar as independent Class I directors with terms expiring in
2025;
- Ratification of appointment of
independent auditors; and
- Approval of current year's
executive compensation and approval of review of executive
compensation on an annual basis going forward.
About Talkspace
Talkspace (NASDAQ: TALK) is a leading virtual behavioral
healthcare company committed to helping people lead healthier,
happier lives through access to high-quality mental healthcare. At
Talkspace, we believe that mental healthcare is core to overall
healthcare and should be available to everyone.
Talkspace pioneered the ability to text with a licensed
therapist from anywhere and now offers a comprehensive suite of
mental health services from self-guided products to individual,
couples and family therapy, in addition to psychiatric treatment
and medication management. With Talkspace’s core psychotherapy
offering, members are matched with one of thousands of licensed
providers across all 50 states and can choose from a variety of
subscription plans including video, text or audio chat sessions
and/or unlimited text messaging.
All care offered at Talkspace is delivered through an
easy-to-use, fully-encrypted web and mobile platform that meets
HIPAA, federal, and state regulatory requirements. Talkspace
covered approximately 77 million lives at June 30, 2022, through
our partnerships with employers, health plans, and paid benefits
programs.
For more information, visit www.talkspace.com.
ContactsFor Investors:Mike Lovell, Senior
Director Investor
Relations515-771-1585Mike.Lovell@Talkspace.com
For Media:SKDKJohn Kim310-997-5963jkim@skdknick.com
Talkspace (NASDAQ:TALK)
Historical Stock Chart
From May 2024 to Jun 2024
Talkspace (NASDAQ:TALK)
Historical Stock Chart
From Jun 2023 to Jun 2024